Research Progress and Clinical Value of Subendocardial Viability Ratio
- PMID: 38471822
- PMCID: PMC11009993
- DOI: 10.1161/JAHA.123.032614
Research Progress and Clinical Value of Subendocardial Viability Ratio
Abstract
Cardiovascular disease remains the leading cause of morbidity and mortality worldwide, with ischemic heart disease being a major contributor, either through coronary atherosclerotic plaque-related major vascular disease or coronary microvascular dysfunction. Obstruction of coronary blood flow impairs myocardial perfusion, which may lead to acute myocardial infarction in severe cases. The subendocardial viability ratio, also known as the Buckberg index, is a valuable tool for evaluation of myocardial perfusion because it reflects the balance between myocardial oxygen supply and oxygen demand. The subendocardial viability ratio can effectively evaluate the function of the coronary microcirculation and is associated with arterial stiffness. This ratio also has potential value in predicting adverse cardiovascular events and mortality in various populations. Moreover, the subendocardial viability ratio has demonstrated clinical significance in a range of diseases, including hypertension, aortic stenosis, peripheral arterial disease, chronic kidney disease, diabetes, and rheumatoid arthritis. This review summarizes the applications of the subendocardial viability ratio, its particular progress in the relevant research, and its clinical significance in cardiovascular diseases.
Keywords: cardiovascular disease; ischemic heart disease; myocardial oxygen supply and demand; myocardial perfusion; subendocardial viability ratio.
Figures


Similar articles
-
Transmural variation in microvascular remodeling following percutaneous revascularization of a chronic coronary stenosis in swine.Am J Physiol Heart Circ Physiol. 2020 Mar 1;318(3):H696-H705. doi: 10.1152/ajpheart.00502.2019. Epub 2020 Feb 14. Am J Physiol Heart Circ Physiol. 2020. PMID: 32056445 Free PMC article.
-
Subendocardial viability ratio in patients with rheumatoid arthritis: comparison with healthy controls and identification of prognostic factors.Clin Rheumatol. 2017 Jun;36(6):1229-1236. doi: 10.1007/s10067-017-3659-9. Epub 2017 Apr 28. Clin Rheumatol. 2017. PMID: 28455826
-
Subendocardial and Transmural Myocardial Ischemia: Clinical Characteristics, Prevalence, and Outcomes With and Without Revascularization.JACC Cardiovasc Imaging. 2023 Jan;16(1):78-94. doi: 10.1016/j.jcmg.2022.05.016. Epub 2022 Sep 14. JACC Cardiovasc Imaging. 2023. PMID: 36599572
-
The role of heart rate in myocardial ischemia and infarction: implications of myocardial perfusion-contraction matching.Prog Cardiovasc Dis. 1993 Jul-Aug;36(1):61-74. doi: 10.1016/0033-0620(93)90022-6. Prog Cardiovasc Dis. 1993. PMID: 8100637 Review.
-
Myocardial perfusion dependent and independent mechanisms of regional myocardial dysfunction in hypertrophy.Basic Res Cardiol. 1993;88 Suppl 1:81-95. doi: 10.1007/978-3-642-72497-8_6. Basic Res Cardiol. 1993. PMID: 8357337 Review.
Cited by
-
Lower estimates of myocardial perfusion are associated with greater aortic perivascular adipose tissue density in humans independent of aortic stiffness.Am J Physiol Heart Circ Physiol. 2024 Oct 1;327(4):H927-H934. doi: 10.1152/ajpheart.00436.2024. Epub 2024 Aug 16. Am J Physiol Heart Circ Physiol. 2024. PMID: 39150391
-
Acute cardiovascular responses to the 100-mi Western States Endurance Run.J Appl Physiol (1985). 2024 Nov 1;137(5):1257-1266. doi: 10.1152/japplphysiol.00412.2024. Epub 2024 Sep 19. J Appl Physiol (1985). 2024. PMID: 39298619
-
Effects of treatment with janus kinase inhibitors on coronary microvascular perfusion in patients with rheumatoid arthritis: an observational prospective cohort study.Rheumatol Int. 2025 Apr 19;45(5):111. doi: 10.1007/s00296-025-05862-y. Rheumatol Int. 2025. PMID: 40252098 Free PMC article.
References
-
- Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, Barengo NC, Beaton AZ, Benjamin EJ, Benziger CP, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76:2982–3021. doi: 10.1016/j.jacc.2020.11.010 - DOI - PMC - PubMed
-
- Severino P, D'Amato A, Pucci M, Infusino F, Adamo F, Birtolo LI, Netti L, Montefusco G, Chimenti C, Lavalle C, et al. Ischemic heart disease pathophysiology paradigms overview: from plaque activation to microvascular dysfunction. Int J Mol Sci. 2020;21:21. doi: 10.3390/ijms21218118 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical